Author:
Banerjee Amrita,Mukherjee Dipanjan,Bera Arpan,Ghosh Ria,Mondal Susmita,Mukhopadhyay Subhadipta,Das Ranjan,Altass Hatem M.,Natto Sameer. S. A.,Moussa Ziad,Ahmed Saleh A.,Chattopadhyay Arpita,Pal Samir Kumar
Abstract
AbstractAnti-microbial resistant infection is predicted to be alarming in upcoming years. In the present study, we proposed co-localization of two model drugs viz., rifampicin and benzothiazole used in anti-tuberculosis and anti-fungal agents respectively in a nanoscopic cationic micelle (cetyl triethyl ammonium bromide) with hydrodynamic diameter of 2.69 nm. Sterilization effect of the co-localized micellar formulation against a model multi-drug resistant bacterial strain viz., Methicillin resistant Staphylococcus aureus was also investigated. 99.88% decrease of bacterial growth in terms of colony forming unit was observed using the developed formulation. While Dynamic Light Scattering and Forsters Resonance Energy Transfer between benzothiazole and rifampicin show co-localization of the drugs in the nanoscopic micellar environment, analysis of time-resolved fluorescence decays by Infelta-Tachiya model and the probability distribution of the donor–acceptor distance fluctuations for 5 μM,10 μM and 15 μM acceptor concentrations confirm efficacy of the co-localization. Energy transfer efficiency and the donor acceptor distance are found to be 46% and 20.9 Å respectively. We have also used a detailed computational biology framework to rationalize the sterilization effect of our indigenous formulation. It has to be noted that the drugs used in our studies are not being used for their conventional indication. Rather the co-localization of the drugs in the micellar environment shows a completely different indication of their use in the remediation of multi-drug resistant bacteria revealing the re-purposing of the drugs for potential use in hospital-born multi-drug resistant bacterial infection.
Funder
APJ Abdul Kalam Technological University
United Arab Emirates University
Publisher
Springer Science and Business Media LLC
Reference97 articles.
1. WHO. Antimicrobial resistance, 2021. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed 10 August 2022).
2. Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0 (2022).
3. Commissioned by the UK Government and the Wellcome Trust., “AMR review, 2016. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (accessed 10 August 2022).
4. Munita, J. M. & Arias, C. A. Mechanisms of antibiotic resistance. Microbiol. Spectr. 4, 2. https://doi.org/10.1128/microbiolspec.VMBF-0016-2015 (2016).
5. Cassini, A. et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet. Infect. Dis 19(1), 56–66. https://doi.org/10.1016/S1473-3099(18)30605-4 (2019).